EDNRA and COVID-19: In summary, we found increased AT1R and ETAR titers in COVID-19 patients compared to controls, but in contrast to our previous report (2), we did not find an increased AT1R and ETAR titer in an unfavorable compared to a favorable COVID-19 disease course.